
Joseph Patrick Erinjeri MD PhD
Member, Memorial Sloan Kettering Cancer Center Professor of Radiology, Weill Cornell Medical College
530 East 74th StreetNew York, NY 10021
Overview of Dr. Erinjeri
Dr. Joseph Erinjeri is an Interventional Radiologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Washington University in St. Louis School of Medicine and has been in practice 15 years. Dr. Erinjeri accepts several types of health insurance, listed below. He is one of 36 doctors at Memorial Sloan Kettering Cancer Center and one of 3 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Interventional Radiology. He has more than 100 publications and over 500 citings.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Vascular and Interventional Radiology, 2007 - 2008
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Vascular and Interventional Radiology, 2007 - 2008
- Washington University/B-JH/SLCH ConsortiumResidency, Radiology-Diagnostic, 2003 - 2007
- Virginia Mason Franciscan HealthInternship, Internal Medicine, 2002 - 2003
- Washington University in St. Louis School of MedicineClass of 2002
Certifications & Licensure
- NJ State Medical License 2017 - 2027
- CT State Medical License 2025 - 2026
- NY State Medical License 2007 - 2026
- PA State Medical License 2025 - 2026
- American Board of Radiology Diagnostic Radiology
- American Board of Radiology Vascular & Interventional Radiology
- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Publications & Presentations
PubMed
- 1 citationsPhase II study of rucaparib and nivolumab in patients with leiomyosarcoma.Sujana Movva, Kenneth Seier, Martina Bradic, Karmelina Charalambous, Evan Rosenbaum
Journal for Immunotherapy of Cancer. 2025-06-12 - 6 citationsA Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.Angela K Green, Qin Zhou, Alexia Iasonos, William A Zammarrelli 3rd, Britta Weigelt
Clinical Cancer Research. 2025-06-03 - 1 citationsEvaluation of the Ki-67 labeling index on immediate pre-ablation biopsies as a predictive biomarker of local recurrence of colorectal cancer liver metastases.Vlasios S Sotirchos, Efsevia Vakiani, Carlie Sigel, Rami Imam, Henry S Kunin
Cytotechnology. 2025-02-01
Authored Content
- Gene Signature Associated with Upregulation of the Wnt/Β-catenin Signaling Pathway Predicts Tumor Response to Transarterial EmbolizationMarch 2018
Press Mentions
- Nirogacestat May Improve Outcomes for People with SarcomaMarch 12th, 2023
- Nirogacestat Improves Outcomes for People with Sarcoma, Shows Phase 3 Clinical TrialMarch 10th, 2023
- Schedule at A GlanceJune 8th, 2015
- Join now to see all
Professional Memberships
- Member
Insurance Accepted
- CIGNA Open Access
CIGNA PPO
GHI PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPOOxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: